Bb5a31f81ClaimFine-tuning open AI models on small, targeted biological datasets can restore dangerous dual-use capabilities excluded during initial pre-trainingAgreeDisagree
Bb5a31f81ClaimJoshua Monrad categorizes biological risks into four phases: human-created bioweapons, AI-enabled human uplift, AI agents socially engineering humans, and end-to-end autonomous AI bioweapon executionAgreeDisagree
Bb5a31f81ClaimDr. Jaspreet Pannu co-authored a paper in the journal Science proposing a managed access governance framework for dual-use biological dataAgreeDisagree
Bb5a31f81ClaimTwo individuals who detonated a chemical explosive device at a California fertility clinic utilized a large language model to inform their attackAgreeDisagree
Bb5a31f81ClaimSentinel Bio has raised tens of millions of dollars and issued approximately 100 philanthropic grants for biosecurity projects as of October 2026AgreeDisagree
Bb5a31f81ClaimControlled pre-training experiments on biological foundation models ESM and Evo demonstrated that withholding specific virus datasets limited human virology capabilities while preserving broader biological functionalityAgreeDisagree
Bb5a31f81ClaimJoshua Monrad dates the emergence of the phase where humans use AI systems for biological weapon design assistance to the late 2010s and early 2020sAgreeDisagree
Bb5a31f81ClaimA biological uplift study co-funded by Sentinel Bio and the Frontier Model Forum and conducted by ActiveSight evaluated 150 participants in a physical wet lab at a cost exceeding one million dollarsAgreeDisagree
Bb5a31f81ClaimA biosecurity evaluation conducted by Anthropic and Deloitte tested the Mythos model on virology protocol execution using a sample size of fewer than 30 PhD-level participantsAgreeDisagree
Bb5a31f81ClaimJoshua Monrad and Janneke Schmidt co-authored a policy proposal for the Institute for Progress titled 'How to Secure the DNA Supply Chain'AgreeDisagree
Bb5a31f81ClaimAs of October 2026, the development of end-to-end autonomous biological weapons without humans in the loop is constrained by robotics capabilities rather than cognitive capabilitiesAgreeDisagree
Bb5a31f81ClaimInternational diplomatic hubs including Geneva, Beijing, and Singapore have a limited number of diplomatic personnel focused on biotechnology governance and biosecurityAgreeDisagree
Bb5a31f81ClaimJoshua Monrad supports enacting a temporary pause on frontier AI biological model training until comprehensive societal biodefenses and supply chain safeguards are operationalAgreeDisagree
Bb5a31f81ClaimBiosecurity monitoring systems can aggregate separate risk signals across proprietary AI query logs, mail-order DNA synthesis orders, and outsourced cloud laboratory requestsAgreeDisagree
Bb5a31f81ClaimSentinel Bio establishes a target victory condition requiring over 80% of global synthetic DNA providers and cloud laboratories to adopt Know-Your-Customer and pre-synthesis screening standardsAgreeDisagree
Bb5a31f81ClaimBenchtop and desktop DNA synthesizers lack standardized hardware security controls, point-of-sale customer verification, and built-in geolocation tracking as of October 2026AgreeDisagree
Bb5a31f81ClaimDouble-stranded synthetic DNA screening protocols evaluate customer orders for known pathogenic sequences and unexplained absence of homology to natural organismsAgreeDisagree
Bb5a31f81ClaimThe International Mission Board's AI charter prohibits giving artificial intelligence autonomous authority in high-risk and high-stakes contextsAgreeDisagree
Bb5a31f81ClaimThe International Mission Board requires human-in-the-loop oversight whenever artificial intelligence is used to generate codeAgreeDisagree
Bb5a31f81ClaimThe International Mission Board's AI policy prohibits artificial intelligence from making final autonomous decisions about peopleAgreeDisagree